DOI:
10.1055/s-00000097
Deutsche Zeitschrift für Onkologie
LinksClose Window
References
Escudier B, Pluzanska A, Koralewski P. et al.
Bevacizumab plus interferon alfa-2a for treatment of
metastatic renal cell carcinoma: a randomised, double-blind phase III
trial.
Lancet 2007; 370 (9605) 2103-11
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.